Ind-Swift Limited (ISL), an Indian pharmaceutical group, said that it has rolled out its finished dosages products in Qatar as part of expanding its presence in the markets of Gulf Cooperation Council (GCC) countries.

Presently in the UAE, Ind-Swift has a total of six products, including line extensions, which are marketed by a dedicated team of four MRs and a national sales manager.

The Indian pharmaceutical group said that it has major growth plans to ramp up the product line to 23 products for the UAE market. In Oman, Ind-Swift Limited has 27 products, including line extensions, under registration with its partner AlHasar Pharmacy.

Ind-Swift Limited stated: “With current 8 products and tie up with its distributor-Wellcare group, Qatar is emerging as a potential focus market for Ind-Swift.”

  Ind-Swift Limited, Qatar